Gaël S Roth (Gael Roth, Gaël Roth, Gael S Roth)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 19

Top Topics

Transcranial Direct Current Stimulation

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

International journal of molecular sciences

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Gaël S Roth, Olivier Hernandez, Najeh Daabek, Bleuenn Brusset, Yann Teyssier, Julien Ghelfi, Marie Noelle Hilleret, Christian Sengel, Ivan Bricault, Thomas Decaens, Charlotte Costentin
Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma. Cancers 14 (7) (2022)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: how does underlying liver disease influence therapeutic strategy and outcomes ? Liver international : official journal of the International Association for the Study of the Liver (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Gaël S Roth, Yohan Fayet, Sakina Benmameche-Medjahed, Françoise Ducimetière, Amandine Charreton, Claire Cropet, Sylvie Chabaud, Anne-Marie Marion-Audibert, Olivier Berthelet, Thomas Walter, Mustapha Adham, Mathieu Baconnier, David Tavan, Nicolas Williet, Pascal Artru, Floriane Huet-Penz, Isabelle L Ray-Coquard, Fadila Farsi, Hélène Labrosse, Christelle De La Fouchardière
Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort. Cancers 14 (21) (2022)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Valentina Lukinović, Simone Hausmann, Gaël S Roth, Clement Oyeniran, Tanveer Ahmad, Ning Tsao, Joshua R Brickner, Alexandre G Casanova, Florent Chuffart, Ana Morales Benitez, Jessica Vayr, Rebecca Rodell, Marianne Tardif, Pascal W T C Jansen, Yohann Cout, Michiel Vermeulen, Pierre Hainaut, Pawel K Mazur, Nima Mosammaparast, Nicolas Reynoird
SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk. Cancer discovery 12 (9) (2022)
Sonia Brun, Eloïne Bestion, Eric Raymond, Firas Bassissi, Zuzana Macek Jilkova, Soraya Mezouar, Madani Rachid, Marie Novello, Jennifer Tracz, Ahmed Hamaï, Gilles Lalmanach, Lise Vanderlynden, Raphael Legouffe, Jonathan Stauber, Thomas Schubert, Maximilian G Plach, Jérôme Courcambeck, Cyrille Drouot, Guillaume Jacquemot, Cindy Serdjebi, Gaël S Roth, Jean-Pierre Baudoin, Christelle Ansaldi, Thomas Decaens, Philippe Halfon
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions. Autophagy (2021)
Marie Malier, Khaldoun Gharzeddine, Marie-Hélène Laverriere, Sabrina Marsili, Fabienne Thomas, Thomas Decaens, Gaël S Roth, Arnaud Millet
Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer. Cancer research 81 (23) (2021)
Gaël S Roth, Maxime Benhamou, Yann Teyssier, Arnaud Seigneurin, Mélodie Abousalihac, Christian Sengel, Olivier Seror, Julien Ghelfi, Nathalie Ganne-Carrié, Lorraine Blaise, Olivier Sutter, Thomas Decaens, Jean-Charles Nault
Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers 13 (4) (2021)
Mariam Mroweh, Gaël S Roth, Thomas Decaens, Patrice N Marche, Herve Lerat, Zuzana Macek Jilkova
Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment. International journal of molecular sciences 22 (4) (2021)
Nicolas Williet, Angelica Petrillo, Gaël S Roth, Michele Ghidini, Mila Petrova, Julien Forestier, Anthony Lopez, Audrey Thoor, Lucie Weislinger, Ferdinando De Vita, Gilles Manceau, Jean Marc Phelip
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study. Cancers 13 (11) (2021)